Νικόλαος Σπυρίδης ΠΑΙΔΙΑΤΡΟΣ-ΛΟΙΜΩΞΙΟΛΟΓΟΣ Director, Clinical Pediatrics

1998- σήμερα:Ιατρικός Σύλλογος Αθηνών
(Αρ.Μητ: 44914, 27/7/98)

1998-σήμερα:General Medical Council, UK (full registration)
(Aρ. Μητ: 4566526)

Μέλος Ιατρικών Συλλόγων1998- σήμερα:Ιατρικός Σύλλογος Αθηνών
(Αρ.Μητ: 44914, 27/7/98)

1998-σήμερα:General Medical Council, UK (full registration)
(Aρ. Μητ: 4566526)

Βασική Εκπαίδευση στη Παιδιατρική και Παιδιατρική Λοιμωξιολογία

Ειδικότητα στην Παιδιατρική

Γενική Παιδιατρική & Νεογνολογία, Νοσοκομείο Pembury, UK

Παιδιατρική Νευρολογία, Νοσοκομείο Guy’s, Λονδίνο, UK

Γενική Παιδιατρική, Νοσοκομείο St Thomas’, Λονδίνο, UK

Νεογνολογία, Νοσοκομείο Guy’s, Λονδίνο, UK

Β΄ Παιδιατρική Κλινική του Πανεπιστημίου Αθηνών. Νοσοκομείο Παίδων Π&Α Κυριακού

Επιμελητής στη Παιδιατρική

Registrar (επιμελητής) στο τμήμα Γενικής Παιδιατρικής. Νοσοκομείο St Thomas’, Λονδίνο

Εξειδίκευση στη Παιδιατρική Λοιμωξιολογία

Fellow στο τμήμα Μικροβιολογίας/Λοιμωξιολογίας. Nοσοκομείου St Thomas’, Λονδίνο

Fellow στην Παιδιατρική Λοιμωξιολογία, St George’s hospital, Λονδίνο

European Society for Paediatric Infectious Diseases (ESPID)

International Union against Tuberculosis and Lung Disease (IUATLD)

BPAIIG (British Paediatric Allergy, Immunology and Infection Group)

Steering Committee, Pediatric Infectious Diseases Society of America (PIDS)

Ελληνική Εταιρία Παιδιατρικών Λοιμώξεων

Συμμετοχή σε θεσμικά επιστημονικά όργανα

• Πρόεδρος της επιτροπής χρήσης αντιβιοτικών (ΟΕΚΟΧΑ)  στο Νοσοκομείου Παίδων «Π&Α Κυριακού» (2016-σήμερα)

• Μέλος της Επιτροπής Νοσοκομειακών Λοιμώξεων  Νοσοκομείου Παίδων «Π&Α Κυριακού» (2014-σήμερα)

• Μέλος του Επιστημονικού Συμβουλίου Νοσοκομείου Παίδων «Π&Α Κυριακού» (2015-2016)

• Μέλος συντονιστικής επιτροπής του Προγράμματος Μεταπτυχιακών Σπουδών ¨Παιδιατρική Λοιμωξιολογία”. ΕΚΠΑ 2016

• Εκπρόσωπος του «Τομέα Υγείας Μητέρας-Παιδιού» στη Γενική Συνέλευση της Ιατρικής Σχολής του ΕΚΠΑ στη βαθμίδα του Επίκουρου Καθηγητή. ΕΚΠΑ 2016-2017

• Μέλος της Επιτροπής «Παιδιατρική Κατ’ οίκον Νοσηλεία (ΠΚΟΝ). Υπό την αιγίδα του Υπουργείου Υγείας. 2021

• Πρόεδρος της Επιτροπής Νοσοκομειακών Λοιμώξεων του Νοσοκομείου Παίδων Π&Α Κυριακού (2021)

• Αντιπρόεδρος της Επιτροπής Αντιμετώπισης COVID-19 στα Παιδιατρικά Νοσοκομεία της 1^ης ΥΠΕ (2021)

• Μέλος της επιτροπής ειδικών για την αντιμετώπιση του COVID19, ΕΚΠΑ. 2021

•  Επιτροπή του Υπουργείου Υγείας για την ειδικότητα στη Παιδιατρική Λοιμωξιολογία. 2024

• Διευθυντής Παιδιατρικού τομέα, Νοσοκομείο Μητέρα (2023)

•  Μέλος επιστημονικού συμβουλίου νοσοκομείου Μητέρα (2023-2024)

Βασική Εκπαίδευση στη Παιδιατρική και Παιδιατρική Λοιμωξιολογία

 Ειδικότητα στην Παιδιατρική

 Γενική Παιδιατρική & Νεογνολογία, Νοσοκομείο Pembury, UK

 Παιδιατρική Νευρολογία, Νοσοκομείο Guy’s, Λονδίνο, UK

 Γενική Παιδιατρική, Νοσοκομείο St Thomas’, Λονδίνο, UK

 Νεογνολογία, Νοσοκομείο Guy’s, Λονδίνο, UK

 Β΄ Παιδιατρική Κλινική του Πανεπιστημίου Αθηνών. Νοσοκομείο Παίδων Π&Α Κυριακού

 Επιμελητής στη Παιδιατρική

 Registrar (επιμελητής) στο τμήμα Γενικής Παιδιατρικής. Νοσοκομείο St Thomas’, Λονδίνο

Εξειδίκευση στη Παιδιατρική Λοιμωξιολογία

Fellow στο τμήμα Μικροβιολογίας/Λοιμωξιολογίας.  Nοσοκομείου St Thomas’, Λονδίνο

Fellow στην Παιδιατρική Λοιμωξιολογία, St George’s hospital, Λονδίνο

Ερευνητικό έργο

• Διπλωματική εργασία

  “Ρόλος του H. Pylori στην ανάπτυξη γαστρίτιδας και έλκους κατά τη παιδική ηλικία”

• Διδακτορική διατριβή

  “Βραχύ σχήμα χημειοπροφύλαξης σε παιδιά με φυματιώδη μόλυνση”

  Δημοσίευση: Clinical Infectious Diseases 2007, 15;45(6): 715-22 

• Επιχορηγούμενη μελέτη

  “APEC study: Antimicrobial Prescribing in European Children”

  Fellowship και χρηματοδότηση: Eυρωπαική Εταιρεία Παιδιατρικών Λοιμώξεων (European Society for Paediatric Infectious Diseases, ESPID)

• Επιχορηγούμενη μελέτη από την Ευρωπαική Ενωση (DG Sanco) με τίτλο: Antimicrobial Prescribing and Resistance in European Children (ARPEC).

• Ημερίδα επιχορηγούμενη από την Ευρωπαϊκή Εταιρία Παιδιατρικών Λοιμώξεων (ESPID) με τίτλο «Collaborative Research Meeting on Hospital Acquired Infections in Europe». Αθήνα 15-16/3/2018

• RANIN (Reducing Antibiotics and Nosocomial Infections in Kids).

• ΝΕΟΝΙΝ (Neonatal Infection Surveillance Network)

• GARPEC (Global Antimicrobial Resistance, Prescribing and Efficacy Among Neonates and Children)

• CLEO I-ΙΙ (Center for Clinical Epidemiology and Outcomes Research)

• Combacte-Care EURECA study

• Eurocandy studυ

• Team-Coach

1. Muco-epidermoid carcinoma of the main bronchus in a 8 years old girl
2. Michail-Stranzia, N. Spyridis, G. Vaos, N. Zavras

49^th Annual Meeting of the Paediatric Pathology Society, Trondheim, Norway

2. Comparison of the Tuberculin RT23-SSI with the tuberculin LOT 5180A Pasteur-Merieux.

P.Spyridis, C.Borra, A.Gelesme, M.Tsolia, N.Myriokefalitakis, N.Spyridis, C.Sinaniotis

17^th Annual Meeting of the European Society for Paediatric Infectious Diseases, Heraklion Crete, 19-21 May, 1999 and 37^th Πανελλήνιο Παιδιατρικό Συνέδριο, Θεσαλλονίκη, 28-30 Μαίου, 1999

3. The impact of the screening program against childhood tuberculosis applied in Greece on the epidemiological indexes in the greater Athens area

Spyridis N, Spyridis P, Tsolia M, Gelesme A, Moustaki M, Spyridis G, Sinaniotis C, Constantopoulos A

5^th International Congress on Pediatric Pulmonology, February 2002, Nice- France

4. Cutaneous tuberculosis in a 4 month old baby

Spyridis N, Tsoukatou Th, Georgouli H, Sakou I, Myriokefalitakis N

X World Congress of Paediatric Dermatology, 7-10 July 2004, Rome

5. Influenza infection in children examined as outpatients
6. Tsolia, I. Logotheti, N. Papadopoulos, M. Mavrikou, N. Spyridis, P. Drossatou, A. Constantopoulos

22^nd Annual Meeting of ESPID, Tempere, Finland, May 26-28, 2004

6. Influenza Infection In Children Examined As Outpatients.

Tsolia MN,  Logotheti I,Papadopoulos NG, Mavrikou M, Spyridis NP, Drossatou P,   Konstantopoulos A.

 22nd  Ann Meet Eur. Soc. Pediatr. Infect. Dis. May 26-28, 2004, Tampere,   Finland.

7. Treatment of latent tuberculosis infection in children and adolescents: a ten year prospective randomized controlled study comparing standard 9   month isoniazid chemotherapy with short course isoniazid and rifampicin             combination regimes.

Spyridis N, Tsolia M, Gelesme A, Valianatou M, Metsou F, Spyridis P

Annual IUATLD meeting, Paris, October 2005

8. Disseminated non-tuberculous mycobacterial infection in a child with INF-γR1 deficiency.

Tsolia MN, Chapgier A, Taprantzi P, Servitzoglou M, Tassios I, Spyridis N, Papageorgiou F, Santos OF, Casanova JL, Spyridis P.

Annual IUATLD meeting, Paris, October 2005

9. Impact of influenza infection on children examined as outpatients and their families.

Tsolia MN, Logotheti I, Papadopoulos NG, Mavrikou M, Spyridis NP, Petraki M, Drossatou P, Κonstantopoulos A.

Second European Influenza Conference. European Scientific Working group on    Influenza, 11-14 September 2005, Malta

10. Drug resistant tuberculosis in Greek children

Kanavaki S, Karambela S, Skroubellou A,Varonou E, Anagnostou S, Raftopoulou, Spyridis N.

Annual IUATLD meeting, Paris, France, October 2005

11. Changing patterns of antibiotic prescribing for UK children in primary care from 1996-2006

Thompson P, Spyridis N, Sharland M, Gilbert R, Saxena S, Long P, Wong I

26^th meeting of the European Society for Paediatric Infectious Diseases, 13-16 May 2008, Graz, Austri 

12. Trends in the epidemiology of childhood tuberculosis in Greece during the last decade and the effect of immigration.

Syridou G, Mavrikou M, Anamatidou V, Spyridis N, Prasad P, Papaventsis D, Kanavaki S, Zaoutis T, Tsolia M.

29^th meeting of ESPID, 2011, Hague, Netherlands

13. Impact of Gen-Probe’s Amplified Mycobacterium Tuberculosis direct test on tuberculosis diagnosis in children

Papaventsis D, Ioannidis P, Karabela S, Nikolaou S, Syridou G, Konstantindou E, Amanatidou V, Marinou I, Panagi M, Spyridis N, Kanavaki S, Tsolia M

29^th meeting of ESPID, 2011, Hague, Netherlands

14. Antimicrobial prescribing guidelines for the treatment of respiratory tract infections in European countries.
15. Syridou, M Tsolia, A. Versporten, N. Spyridis

30^th meeting of ESPID, 2012, Thessaloniki, Greece

15. Antimicrobial prescribing guidelines for the treatment of neonatal sepsis in European countries
16. Syridou, M. Tsolia, A. Versporten, N. Spyridis

30^th meeting of ESPID, 2012, Thessaloniki, Greece

 16.Three way comparison of the performance of the tuberculosis skin test and interferon-gamma assays for detecting tuberculosis infection among children.

Myrsini Mavrikou, Elena Critselis, Nikos Spyridis, Kyriaki Benetatou, Maria Tsagaraki, Alexandra Soldatou, Chrysa Bakoula, Maria N. Tsolia

31th meeting of ESPID, 2013, Milan, Italy

17. Determinants for tuberculosis infection among children investigated with interferon gamma release assays and having contact with adult tuberculosis cases.

Elena Critselis, Nikos Spyridis, Mersini Mavrikou, Kyriaki Benetatou, Kyriaki Karavanaki, Chrysa Bakoula, Maria N. Tsolia.

31^st meeting of ESPID, 2013, Milan-Italy

18. A nationwide point prevalence survey for assessing variations in antibiotic use among neonatal and paediatric patients in Greece.

Spyridis N, Syridou G, Mougkou K, Kouni S, Roilidis E, Gkentzi D, Ladomenou F,  Critselis E, Versporten A, Zaoutis T.

31^st meeting of ESPID, 2013, Milan-Italy

 A survey for assessing the availability of antibiotic prescribing guidelines in paediatric hospitals in Europe

Syridou G, Tsolia M, Versporten A, Spyridis N

31^st meeting of ESPID, 2013, Milan-Italy

20. Antibiotic Prescribing Guidelines for Urinary Tract Infection in Children: What are we currently recommending in European hospitals?

Syridou G, Tsolia M, Versporten A, Spyridis N

31^st meeting of ESPID, 2013. Milan-Italy

21. Hepatitis B immunity in children with JIA at disease onset

Maritsi D, Vartzelis G, Soldatou A, Spyridis N

Annual Meeting of European Congress of Rheumatology. Madrid, Spain 2013

21. Developing a European neonatal infection surveillance network.

Kortsalioudaki C, Kent A, Lutsar I, Metsvaht T, Zaoutis T, Spyridis N, Kopsidas J, Karachristou K, Gketzi D, Dimitriou G, Heath PT

32^nd Annual Meeting of ESPID, Dublin 2014          

22. A European hospital survey on duration of antibiotic therapy for common paediatric infections: what is currently recommended?

G Syridou, G. Kourlaba, Versporten A, Tsolia M, Spyridis N       

32^nd Annual Meeting of ESPID, Dublin 2014

23. Antibiotic prescribing in ambulatory pediatrics in Greece, 2010-2013
24. Kourlaba, Spyridis N, Kopsidas J, Lourida A, Mougkou K, Manta-Maroudi S, Zaoutis T.

32^nd Annual Meeting of ESPID, Dublin 2014

24. Klebsiella hospital acquired infection (HAI) in neonates in Europe-Data from the Noenin surveillance network.

Kortsalioudaki C, Kent P, Clarke P, Lutsar I, Kennea N, Watts T, Bedford-Russell   A, Kopsidas J, Spyridis N, Anatolitou F, Zaoutis T, Heath P.T

33^rd  Annual Meeting of ESPID, Leipzig 2015

25. Neonatal Infection Surveillance in Greece-Data from a European Network.

 Gentzi D, Kortsalioudaki C, Kent A, Kopsidas J, Spyridis N, Anatolitou F, Zannikos K, Zaoutis T, Karachristou K, Siachanidou T, Charitou A, Dilanas M, Stratiki Z, Spanopoulou I, Peristeri V, Skordala M, Manoura A, Nyktari G, Dimitriou G, Heath P.T

33^rd  Annual Meeting of ESPID, Leipzig 2015

26. Gram negative bacteria causing late onset neonatal sepsis-A comparison between two European countries.

Gkentzi D, Kortsalioudaki C, Kent A, Kopsidas J, Spyridis N, Anatolidou F, Zannikos K, Zaoutis T, Karachristou K, Siachanidou T, Charitou A, Stratiki Z, Peristeri V, Skordala M, Manoura A, Nyktari G, Dimitriou G, Heath P.T

33^rd  Annual Meeting of ESPID, Leipzig 2015

27. Prolonged dual antibiotic courses for culture positive neonatal sepsis in 3 Greek neonatal units

Kospidas J, Lianou L, Kourkouni E, Karachristou K, Stratiki E, Vintila A, Karaviti D, Kirikas Z, Baglatzi L, Mougkou K, Pappa M, Tsolia M, Zaoutis T, Spyridis N

33^rd  Annual Meeting of ESPID, Leipzig 2015

28. Epidemiological study of childhood bacteraemia during a 7-year period

(2007-2013)

Doudoulakakis A, Bozavoutoglou E, Hatzaki D, Vetouli E.E, Goumenopoulos C, Matsas M, Troupi A, Doxa E, Spyridis N, Paraskakis I, Tsolia M, Lebessi E. 33^rd Annual Meeting of ESPID, Leipzig 2015

29. The immune response to Hepatitis A Vaccine in Children with Pfapa Syndrome

Maritsi D, Vartzelis G, Spyridis N, Garoufi A, Diamantopoulos S

Annual European Congress of Rheumatology, Rome 2015

30. The immune response to Hepatitis A vaccine in children with autoinflammatory disorders

Maritsi D, Vartzelis G, Metaxa Z, Vougiouka O, Spyridis N, Diamantopoulos S

Annual European Congress of Rheumatology, Rome 2015

31. Immunogenicity and safety of the inactivated hepatitis A vaccine in children with JIA on immunosuppressive theatment: a matched case-control study

Maritsi D, Coffin S, Spyridis N, Vartzelis G

34^th Annual Meeting of ESPID, Brighton 2016

32. Immunogenicity and safety of the inactivated hepatitis A vaccine in children with PFAPA syndrome: a prospective controlled observational cohort study

Maritsi D, Syrmou A, Vartzelis G, Spyridis N

34^th Annual meeting of ESPID, Brighton 2016

33. Determinants of non compliance to hospital antibiotic guidelines for the empiric treatment of LRTI in children in Europe: An ARPEC project analysis

Spyridis N, Versporten A, Kopsidas J, Syridou G, Kourkouni E, Drapier N, Tsolia M, Sharland M, Goossens H.

34^th Annual meeting of ESPID, Brighton 2016

34. SSTI caused by Staph. aureus strains resistant to mupirocin and fusidic acid are emerging in Athens, Greece

Doudoulakakis A, Pneumatikou P, Paradisis G, Spyridis N, Tsolia M, Paraskakis I, Lebessi E.

34^th Annual meeting of ESPID, Brighton 2016

35. Antimicrobial point prevalence survey (PPS) and guidelines for neonatal sepsis in Greek neonatal units and comparison to the UK.

Gkentzi D, Kortsalioudaki C, Kennea N, Greenough A, Watts T, Kopsidas J, Spyridis N, Karachristou K, MavrogeorgosG, Chang J, Kundu A et al.

34^th Annual meeting of ESPID, Brighton 2016

36. Neonatal infections in Greece-data from a European infection surveillance network

Gkentzi D, Kortsalioudaki C, Cailes B, Kopsidas J, Spyridis N et al

34^th Annual meeting of ESPID, Brighton 2016

37. Comparison of the epidemiology of neonatal infections between two European countries from the NEONIN infection network

Gkentzi D, Kortsalioudaki C, Cailes B, Kopsidas J, Spyridis N et al

34^th Annual meeting of ESPID, Brighton 2016

38. Healthcare associated factors correlated with neonatal coagulase negative staphylococcus spp infection.

Wang J, Anthony M, Tan K, Buttery J, Watts T, Scorrer T, Spyridis N, Zaoutis T, Kopsidas J, Kortsalioudaki C.

35^th Annual meeting of ESPID, Madrid 2017

39. Healthcare associated factors correlated with nosocomial neonatal enterococcal infection.

Wang J, Anthony M, Tan K, Buttery J, Watts T, Scorrer T, Spyridis N, Zaoutis T, Kopsidas J, Kortsalioudaki C.

35^th Annual meeting of ESPID, Madrid 2017

40. Tuberculosis among adolescents in a non-endemic country.

 Syridou G, Spyridis N, Antonogeorgos G, Liakea M, Papavasileiou A, Tsolia M.

 35^th Annual meeting of ESPID, Madrid 2017

41. Key determinants for the development of recurrent invasive infections in neonates: data from the NEONIN network

Kopsidas J, Cortsalioudaki C, Kourkouni E, Witney A, Watts T, Scorrer T, Zaoutis T, Spyridis N, Heath P

35^th Annual meeting of ESPID, Madrid 2017

42. Infections among refugee and immigrant children in Athens. Is there anything to worry about?

Syngelou A, Benetatou K, Dasoula F, Spyridis N, Tsolia M

35^th Annual meeting of ESPID, Madrid 2017

43. Epidemiology of enterococcus spp. Infections from the NEONIN infection surveillance network

Wang J, Kortsalioudaki C, Heath P, Buttery J, Watts T, Scorrer T, Spyridis N, Kopsidas J, Tan K

35^th Annual meeting of ESPID, Madrid 2017

44. BCG vaccine protects against latent TB infection among children in close contact with infectious adult TB cases

Syngelou A, Spyridis N, Benetatou K, Tsagaraki M, Tsolia M

35^th Annual meeting of ESPID, Madrid 2017

45. NEONATES TREATED FOR MENINGITIS IN A NEONATAL INFECTION SURVEILLANCE NETWORK ON BEHALF OF THE NEONATAL INFECTION SURVEILLANCE NETWORK (NEONIN)
46. Kopsidas, C. Kortsalioudaki, E. Kourkouni, N. Spyridis, T.E. Zaoutis, P.T. Heath

36^th Annual meeting of ESPID, Malmo 2018

46. CULTURE-PROVEN INFECTIONS IN LATE PRETERM INFANTS IN A NEONATAL INFECTION SURVEILLANCE NETWORK ON BEHALF OF THE NEONATAL INFECTION SURVEILLANCE NETWORK (NEONIN)
47. Kortsalioudaki , I. Kopsidas, E. kourkouni, N. Spyridis, T.E. Zaoutis, P.T. Heath

36^th Annual meeting of ESPID, Malmo 2018

47. LONG-TERM PRESERVATION OF MEASLES AND RUBELLA SPECIFIC-IGG ANTIBODIES IN CHILDREN WITH JUVENILE SPONDYLARTHRITIS ON ANTI-TNF-a TREATMENT- A PROSPECTIVE CONTROLLED STUDY
48. Maritsi, N. Spyridis, J. Kopsidas, M. Tsolia

36^th Annual meeting of ESPID, Malmo 2018

48. LONG-TERM PERSISTENCE OF RUBELLA AND MEASLES ANTIBODIES IN CHILDREN WITH JUVENILE SCLERODERMA ON IMMUNOSUPPRESSIVE TREATMENT- A CASE CONTROL STUDY.
49. Maritsi, I. Eleftheriou, N. Spyridis, M. Tsolia

36^th Annual meeting of ESPID, Malmo 2018

49. VACCINATION DURING PREGNANCY: WOMEN IN GREECE ARE UNAWARE AND EXPRESS CONCERNS FOR SAFETY
50. Kopsidas, F.E. Dasoula, C. Mystakelis, E. Kourkouni, D.N. Maritsi, G. Vartzelis, M. Tsolia, N. Spyridis

36^th Annual meeting of ESPID, Malmo 2018

50. VARIABILITY OF LENGTH OF THERAPY FOR POSSIBLE EARLY ONSET SEPSIS(EOS) AND LATE ONSET SEPSIS(LOS): IDENTIFYING OPPORTUNITIES FOR ANTIBIOTIC STEWARDSHIP IN THE NEONATAL INTENSIVE CARE UNIT(NICU)
51. Kopsidas, E. Bouza, T. Gouvias, A. Kaffe, K. Karachristou, E. Kourkouni, G. Mavrogeorgos, E. Roilides, T. Siahanidou, V. Soubasi, N. Spyridis, E. Stratiki, M. Theodoraki, P. Triantafyllidou, A. Tsintoni, G.C. Tsopela, M. Tzaki, T.E. Zaoutis

36^th Annual meeting of ESPID, Malmo 2018

51. COMMUNITY ONSET CENTRAL LINE ASSOCIATED BLOODSTREAM INFECTIONS (CLABSIS) IN PEDIATRIC ONCOLOGY PATIENTS: AN UNDERESTIMATED PROBLEM?
52. Kopsidas, S. Papachristidou, E. Kourkouni, M. Baka, A. Pourtsidis, G.C. Tsopela, M. Tsolia, S. Coffin, T.E. Zaoutis, D. Doganis, N. Spyridis

36^th Annual meeting of ESPID, Malmo 2018

52. RISK FACTORS FOR COMMUNITY ONSET CENTRAL LINE ASSOCIATED BLOODSTREAM INFECTIONS (CO-CLABSIS) IN PEDIATRIC ONCOLOGY PATIENTS
53. Papachristidou, I. Kopsidas, M. Baka, A. Pourtsidis, E. Kourkouni, G.C. Tsopela, M. Tsolia, S. Coffin, T.E. Zaoutis, N. Spyridis, D. Doganis

36^th Annual meeting of ESPID, Malmo 2018 

53. ANTIBIOTIC USE AND OVERUSE AMONG PRESCHOOL CHILDREN ATTENDING DAY CARE CENTERS
54. Patouni, G. Kourlaba, N. Spyridis, I. Eleftheriou, T. Zaoutis, M. Tsolia

36^th Annual meeting of ESPID, Malmo 2018

54. MANAGEMENT OF ASYMPTOMATIC CHILDREN WITH TST(+) BUT IGRA(-) RESULTS IN A LOW PREVALENCE SETTING; A 10-YEAR FOLLOW-UP EXPERIENCE
55. Syngelou , K. Benetatou , M. Tsagaraki , I. Eleftheriou, N. Spyridis, M. Tsolia

36^th Annual meeting of ESPID, Malmo 2018

55. Blood stream infection in children with cancer: a 7 year experience at a single center.

Sfetsiori AE, Doganis D, Doudoulakakis A, Spyridis N, Pourtsidis A, Servitzoglou M, Kapetaniou K, Nikita M, Tsolia M.

37^th Annual meeting of ESPID, Ljubliana 2019

56. Gram- Vs Gram + blood stream infections in children with cancer

Sfetsiori AE, Doganis D, Doudoulakakis A, Lebessi E, Pourtsidis A,  Spyridis N, Kosmidis H, Baka M, Tsolia M.

37^th Annual meeting of ESPID, Ljubliana 2019

57. Evaluation of immigrant children referred for a positive test with IGRA: a 4 year experience at a tuberculosis referral center.

Syngelou A, Kopsidas I, Benetatou K, Maritsi D, Brouskaki N, Tsagaraki M, Tsolia M, Spyridis N.

37^th Annual meeting of ESPID, Ljubliana 2019

58. Risk factors for healthcare associated infections after pediatric cardiac surgery

Prapa M, Spyridis N, Barbaresou C.

37^th Annual meeting of ESPID, Ljubliana 2019

59. Infectious diseases among refugee children at a tertiary care children’s hospital in Greece

Dasoula FE, Syngelou A, Benetatou K, Eleftheriou I, Spyridis N, Tsolia M

 37^th Annual meeting of ESPID, Ljubliana 2019

60. Recent measles outbreak in Greece. Epidemiology of cases at a tertiary care children’s hospital.

Dasoula FE, Papatesta, EM, Damianaki A, Eleftheriou I, Syngelou A, Koumparelou A, Mavrikou M, Spyridis N, Tsolia M

37^th Annual meeting of ESPID, Ljubliana 2019

61. Identifying targets for improvement of PAP in a tertiary children’s hospital.

Vlachou A, Kopsidas I, Panagos D, Radiotis A, Spyridis N, Tsolia M

 37^th Annual meeting of ESPID, Ljubliana 2019

62. HAI surveillance among 11 EU countries, A RANIN survey

Kopsidas I, Bielicki J, Blazquez-Gasmero D, Brett A, Collins M, Cunney R, De Luca M, Dona D, Drysdale S, Epalza C, Falup-Pecurariu O, Iosifidis E, Klein N, Lutsar I, Mougkou A, Neth O,  Spyridis N

37^th Annual meeting of ESPID, Ljubliana 2019

63. Hand hygiene compliance rates in 9 pediatric intensive care units across Europe: results form the RANIN-Kids network

DeLuca M, Kopsidas I, Machaira M, Bielicki J, Elpanza C, Lembo G, Spyridis N, Zaoutis T

38^th Annual meeting of ESPID, Rotterdam 2020 (βράβευση καλύτερης παρουσίασης)

64.Early discontinuation of empiric antibiotic therapy in children with acute    lymphoblastic leukemia and febrile neutropenia

Papachristidou S, Doganis D, Baka M, Pourtsidis A, Papaevengelou V, Tsolia M, Spyridis N

38^th Annual meeting of ESPID, Rotterdam 2020

65. Surgical antibiotics prophylaxis practices in children among 10 European countries. A RANIN kids study

Kopsidas I, Brett A, Daniele D, Romanengo M…Zaoutis T, Spyridis N

38^th Annual meeting of ESPID, Rotterdam 2020

66. Burden and epidemiological characteristics of infectious diseases among refugee children presenting at a tertiary care children’s hospital in Athens, Greece

Dasoula F, Damianaki A, Eleftheriou I, Vlachou A, Papailiou S, Maritsi D, Syngelou A, Spyridis N, Tsolia M

38^th Annual meeting of ESPID, Rotterdam 2020

67. Factors contributing to non-compliance with surgical antibiotic prophylaxis in Pediatric Cardiac Surgery patients

Prapa M, Tzalavra S, Agrogianni X, Barbaresou C, Spyridis N

38^th Annual meeting of ESPID, Rotterdam 2020

68. Novel cytokine biomarkers in quantiferon supernatants improve distinction of children with active TB from those with pneumonia and latent TB

Syngelou A, Taka S, Lakoumenta J, Brouskaki N, Kaforou M, Eleftheriou I, Spyridis N, Papadopoulos N, Tsolia M

38^th Annual meeting of ESPID, Rotterdam 2020

69. Perioperative antimicrobial prophylaxis in a tertiary children’s hospital.

Vlachou A, Kopsidas I, Tzortzopoulou A, Dasoula F, Kaliviotis I, Passalidis A, Spyridis N, Tsolia M

38^th Annual meeting of ESPID, Rotterdam 2020

70. Early diagnosis of chronic granulomatous disease in a neonate

Papastamatiou T, Tataropoulou K, Eleftheriou I, Spyridis N, Angela N, Tsolia M

38^th Annual meeting of ESPID, Rotterdam 2020

71. Correlation between stool bacterial colonization and empiric antibiotic therapy in oncology patients with confirmed bacteraemia

Galani V, Sfetsiori A E, Doganis D, Kosmidis H, Spyridis N

38^th Annual meeting of ESPID, Rotterdam 2020

72. Impact of antimicrobial stewardship programs on length of stay, mortality, readmissions and cost in PICU: a systematic review

Kopsidas I, Triantafyllou C, Tsopela G C, Liosi A, Liapodimitri AE, Kourkouni E, Spyridis N, Zaoutis T

39^th Annual meeting of ESPID, Geneva 2021

73. Impact of neonatal ASP on length of stay, mortality and cost: a systematic review

Kopsidas I, Triantafyllou C, Tsopela G C, Liosi A, Kourkouni E, Spyridis N, Zaoutis T

39^th Annual meeting of ESPID, Geneva 2021

74. Pericarditis as the main clinical manifestation of COVID-19 in adolescents

Dimopoulou D, Spyridis N, Dasoula F, Krepis P, Eleftheriou E, Liaska M, Servos  G, Maritsi D, Tsolia M

39^th Annual meeting of ESPID, Geneva 2021

75. Mild clinical course and favorable outcome in infants <12 months old hospitalized with COVID-19

Dimopoulou D, Eleftheriou E, Liaska M, Krepis P, Dasoula F, Maritsi D, Tsolia M, Spyridis N

39^th Annual meeting of ESPID, Geneva 2021

76. The effect of a “handshake” antibiotic stewardship approach on the management of children with RSV bronchiolitis

Papatesta M, Kourkouni E, Papadimitriou M, Matsas M, Dasoula F, Kopsidas I, Tsolia M, Spyridis N

39^th Annual meeting of ESPID, Geneva 2021 (βραβείο καλύτερης παρουσίασης)

77. SARS-CoV-2 screening results in a tertiary children’s hospital during the second wave of the pandemic

Eleftheriou I, Drakaki A, Lebessi E, Spyridis N, Tsolia M

39^th Annual meeting of ESPID, Geneva 2021

78. Real life evaluation of the Panbio COVID-19 rapid antigen detection test in children

Eleftheriou I, Dasoula F, Dimopoulou D, Lebessi E, Serafi E, Spyridis N, Tsolia M

39^th Annual meeting of ESPID, Geneva 2021

79. Neurolisteriosis in an 8 year old immunocompetent girl

Krepis P, Eleftheriou I, Maritsi D, Bozavoutoglou E, Tsolia M, Spyridis N

39^th Annual meeting of ESPID, Geneva 2021

80. COVID-19 vaccine uptake among healthcare workers in a tertiary children’s hospital in Athens

Dasoula F, Liaska M, Eleftheriou I, Dimopoulou D, Maritsi D, Spyridis N, Tsolia M

39^th Annual meeting of ESPID, Geneva 2021

81. Perioperative colonization and postoperative infections in pediatric cardiac surgery patients

Prapa M, Tzalavra X, Barbaresou C, Spyridis N

39^th Annual meeting of ESPID, Geneva 2021

82. CHARACTERISTICS OF CHILDREN HOSPITALIZED WITH MIS-C DURING THREE PANDEMIC WAVES IN GREECE

Irini Eleftheriou, Despoina Maritsi, Stavroula Lampidi, Evaggelia Farmaki,Konstantina Charisi, Petrina Vantsi, Kleopatra Skourti, Filippos Filippatos, Ioannis Amplianitis, Parthena Kampouridou, Ioanna Grivea, Kyriaki Papadopoulou-Legbelou, Efimia Papadopoulou-Alataki, Eleni Vergadi, Despoina Gkentzi, Despina Dimou1, Patra Koletsi1, Lampros Fotis, Vassiliki Papaevangelou, Emmanouil Galanakis, George Syrogiannopoulos, Vassiliki Spoulou, Nikos Spyridis, Athanasios Michos, Emmanuel Roilides, Maria Tsolia

            40^th Annual Meeting of ESPID, Athens 2022

83. COVID-19 breakthrough disease in fully vaccinated paediatric patients with rheumatic diseases.

Irini Eleftheriou, Nikos Spyridis, Lydia Kossiva, Olga Vougiouka, Maria Tsolia, Despoina   Maritsi

40^th Annual Meeting of ESPID, Athens 2022

84. Impact of COVID-19 on antimicrobial consumption in hospitalized children

Dimitra Dimopoulou, Nikos Spyridis, Eirini Tzaladima, Anastasia Papaioannou, Alexandros Douvanas, Ekaterini Tsantila, Irini Eleftheriou, Maria Tsolia, Theoklis Zaoutis

40^th Annual Meeting of ESPID, Athens 2022

85. Antimicrobial prescribing in hospitalized children with COVID-19

Dimitra Dimopoulou, Nikos Spyridis, Irini Eleftheriou, Marianthi Liaska, Foteini Dasoula, Aggeliki Syggelou, Theoklis Zaoutis, Maria Tsolia

40^th Annual Meeting of ESPID, Athens 2022

86. Management of infants 29-60 days old hospitalized with fever: time to revisit practice guidelines

Irini Eleftheriou, Ariadni Neofytou, Anastasios Doudoulakakis, George Kalogeras, Katerina Tsiligianni, Evaggelia Eirini Vetouli, Evangelia Lebessi, Maria Tsolia, Nikos Spyridis

40^th Annual Meeting of ESPID, Athens 2022

87. Seroprevalence of SARS-CoV-2 infection among children and their parents in Greece

Dimitra Dimopoulou, Maria Kyritsi, Eleni Vergadi, Ekaterini Tsiligianni, Eleni Papadimitriou, Artemis Mavridi, Spyridon Giannakopoulos, Georgia Tsiourvopoulou, Maria Palyvou, Evangelia Angeli, Nikitas Brikos, Irini Eleftheriou, Nikos Spyridis, Athanasios Michos, Vassiliki Spoulou, Despoina
Gkentzi, Ekaterini Siomou, Vassiliki Papaevangelou, George Syrogiannopoulos, Emmanouil Galanakis, Christos Hadjichristodoulou, Maria Tsolia

40^th Annual Meeting of ESPID, Athens 2022

88. MISC: a nationwide collaborative study in the Greek population

Stavroula Lampidi, Despoina Maritsi, Irini Eleftheriou, Evaggelia Farmaki, Nikos Spyridis, Konstantina Charisi, Petrina Vantsi, Filippos Filippatos, Kleopatra Skourti, Efimia Papadopoulou-Alataki, Kyriaki Papadopoulou-Legbelou, Parthena Kampouridou, Ioanna Grivea, Eleni Vergadi, Despoina
Gkentzi, Despina Dimou, Patra Koletsi, Lampros Fotis, Vassiliki Papaevangelou, Gabriel Dimitriou, Emmanouil Galanakis, George Syrogiannopoulos, Vassiliki Spoulou, Athanasios Michos, Emmanuel Roilides, Maria Tsolia

40^th Annual Meeting of ESPID, Athens 2022

89. Use of mixovirus resistance protein A (MxA) as a biomarker for the differentiatial diagnosis between viral and bacterial infections in febrile infants without a source

Korentzelou V, Eleftheriou I, Mavrikou M, Tsolia M, Spyridis N

41^st Annual Meeting of ESPID, Lisbon, 2023

90. Inflammatory and endothelial biomarkets associatyed with post COVID-19 infection in children

Karaviti D, Charakida M, Dimopoulou D, Eleftheriou I, Maritsi D, Marmarinos A, Avgeris M, Gourgiotis D, Spyridis N, Tsolia M.

41^st Annual Meeting of ESPID, Lisbon, 2023

91. Rise of neurological manifestations during SARS-CoV-2 omicron wave in children with COVID-19

Dimopoulou D, Dasoula F. E, Liaska M, Eleftgheriou I, Maritsi D, Spyridis N, Vartzelis G, Tsolia M

41^st Annual Meeting of ESPID, Lisbon, 2023

92. Trends in epidemiology of childhood TB in Greece in the last decade

Syngelou A, Spyridis N, Kopsidas I, Brouskaki N, Benetatou K, Eleftheriou I, Tsolia M

41^st Annual Meeting of ESPID, Lisbon, 2023

93. Accuracy of serum PCT for the early diagnosis of sepsis in neonates: a systgematic review and meta-analysis

Markante A, Spyridis N, Kourkouni E, Kousi D.

42^st Annual Meeting of ESPID, Kopenhagen, 2024

Δημοσιεύσεις σε διεθνή επιστημονικά περιοδικά

1. The impact of Greece’s childhood tuberculosis screening programme on the epidemiological indexes in the greater Athens area
2. Spyridis, M. Tsolia, A. Gelesme, M.Moustaki, N. Spyridis, C. Sinaniotis, T. Karpathios

Int J Tuberc Lung Dis, 2003, 7(3): 248-253

2. Simultaneous presentation of Henoch Schonlein purpura in monozygotic twins

Nikos Spyridis, Marianella Salapata, Smaragdi Fessatou, Chrisi Kontaxaki, Panayiotis Spyridis

Scand. J. Infect. Dis. 2005;37(9):703-4

3. Severe disseminated tuberculosis in a 4 month old infant initially presented with multiform cutaneous lesions

Nikos Spyridis, Heleni Georgouli, Theano Tsoukatou, Irini Sakou, Maria Tsolia, Nikos Miriokefalitakis, Panayiotis Spyridis

Scand J Infect Dis. 2006;38(4):306-8.

4. Disseminated nontuberculous mycobacterial infection in a child with interferon- gamma R1 deficiency

Tsolia M, Chapgier A, Taprantzi P, Servitzoglou M, Tassios I, Spyridis N, Papageorgiou F, Santos OF, Casanova JL, Spyridis P.

Eur J Pediatr. 2006 Jul;165(7):458-461. Epub 2006 Apr 7

5. Impact of influenza infection in healthy children examined as outpatients and their families.

Tsolia M, Logotheti I, Papadopoulos N, Mavrikou M, Spyridis N, Drossatou P, Kafetzis D, Konstantopoulos A: The outpatient Flu study group

Vaccine. 2006 Aug 14;24(33-34):5970-6

6. Early diagnosis of tuberculosis using an INF-γ assay in a child with HIV-1 infection and a very low CD-4 count.
7. N. Spyridis, R. Chakraborty, M. Sharland, P. Heath

Scand. J. Infec. Dis. 2007;39(10):919-21

7. The effectiveness of a 9 month regimen of isoniazid alone versus 3 and 4 month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11 year randomized study

Spyridis N, Spyridis P, Gelesme A, Valianatou M, Metsou F,Gourgiotis D, Sypsa V, Tsolia M

Clin Infect Dis. 2007, 15;45(6): 715-22

8. The European Union Antibiotic Awareness Day: the paediatric perspective.

Spyridis N, Sharland M

Arch Dis Child. 2008 Nov;93(11):909-10

9. Changes in clinical indication for community prescribing for children in the UK from 1996-2006: will the new NICE prescribing guidance on upper respiratory tract infections be ignored?

Thompson PL, Spyridis N, Sharland M, Gilbert RE, Saxena S, Long PF, Johnson AP, Wong IC.

Arch. Dis. Child 2009 May;94(5):337-40

10. Increasing skin infections and staphylococcus aureus complications in children, England, 1997-2006

Saxena S, Thompson P, Birger R, Bottle A, Spyridis N, Wong I, Johnson AP, Gilbert R, Sharland M; Improving Children’s Antibiotic Prescribing Group.

Emerg Infect Dis. 2010 Mar; 16(3):530-3

11. Off label antibiotic use in children in three European countries.

Porta A, Esposito S, Menson E, Spyridis N, Tsolia M, Sharland M, Principi N.

Eur J Clin Pharmacol. 2010 Sep;66(9):919-27

12. Whole blood interferon-γ release assay is a useful tool for a diagnosis of tuberculosis infection particularly among Bacille Calmette Guerin- vaccinated children.

Tsolia MN, Mavrikou M, Critselis E, Papadopoulos NG, Makrinioti H, Spyridis NP, Metsou F, Tsagaraki M, Koulouri M, Kafetzis DA.

Paediatr Infect Dis J. 2010 Dec;299 (12): 1137-40

13. Antibiotic use for upper respiratory tract infections in children: a cross sectional survey of knowledge, attitudes and practices (KAP) of parents in Greece

Panagakou SG, Spyridis N, Papaevangelou V, Theodoridou KM, Goutziana GP, Theodoridou MN, Syrogiannopoulos GA, Hadjichristodoulou CS.

BMC Pediatr 2011 Jul 5;11:60

14. Dosing of oral penicillins in children: is big child=half an adult, small child=half a big child, baby=half a small child still the best we can do?

Ahmed U, Spyridis N, Wong IC, Sharland M, Long PF.

BMJ 2011 Dec 15;343:d7803

15. Impact of Gen-Probe Amplified MTD Test on tuberculosis diagnosis in children

Papaventsis D, Ioannidis P, Karabela S, Nikolaou S, Syridou G, Marinou I, Konsantinou E, Amanatidou V, Spyridis N, Kanavaki S, Tsolia M

Int J Tuberc lung Dis. 2012 Jan 5.

16. Comparing neonatal and paediatric antibiotic prescribing between hospitals: a new algorithm to help international benchmarking.

Porta A, Hsia Y, Doerholt K, Spyridis N, Bielicki J, Menson E, Tsolia M, Esposito S, Wong IC, Sharland M

J Antimicrob Chemother. 2012 May;67(5):1278-86

17. Trends in the epidemiology of childhood tuberculosis in Greece

Syridou G, Mavrikou M, Amanatidou V, Spyridis N, Prasad P, Papaventsis D, Kanavaki S, Zaoutis T, Tsolia MN

Int J Tuberc Lung Dis.2012 Jun;16(6):749-55

18. The Effect of Age on Whole Blood Interferon-Gamma Release Assay response among Children Investigated for Latent Tuberculosis Infection.

Critselis E, Amanatidou V, Syridou G, Spyridis NP, Mavrikou M, Papadopoulos NG, Tsolia MN.

J Pediatr. 2012 Oct;161(4):632-8

19. MenACWY-TT vaccine for active immunization against invasive meningococcal disease.

Papaevangelou V, Spyridis N

Expert Rev Vaccines. 2012 May;11(5):523-37

20. Colonization of high risk children with Carbapenemase Producing Enterobacteriaceae (CPE) in Greece.

Mougkou K, Michos A, Spyridopoulou K, Daikos GL, Spyridis N, Syriopoulou V, Zaoutis T

Infect Control Hosp Epidemiol. 2013. Jul;34(7):757-9

21. Markedly decreased antibody titers against hepatitis B in previously immunised children presenting with juvenile idiopathic arthritis.

Maritsi D, Vartzelis G, Soldatou A, Garoufi A, Spyridis N.

Clin Exp Rheumatol. 2013 Nov-Dec;31(6):969-73. Epub 2013 Jun 26

22. Assessment of hand hygiene resources and practices at the 2 children’s hospitals in Greece.

Kouni S1, Kourlaba G, Mougkou K, Maroudi S, Chavela B, Nteli C, Lourida A, Spyridis N, Zaoutis T, Coffin S.

Pediatr Infect Dis J. 2014 Oct;33(10):e247-51

23. Antimicrobial prescribing and expenditures in outpatient paediatrics in Greece, 2010-13.

Kourlaba G, Kourkouni E, Spyridis N, Gerber JS, Kopsidas J, Kougkou K, Lourida A, Zaoutis TE

J Antimicrob Chemother. 2015 Apr 16.

24. Variation in paediatric hospital antibiotic guidelines in Europe

Spyridis N, Syridou G, Goossens H, Versporten A, Kopsidas J, Kourlaba G, Bielicki J, Drapier N, Zaoutis T, Tsolia M, Sharland M.

Arch Dis Child 2015 Sep 18

25. An infant with purpuric rash and edema.

Argyri I, Korona A, Mougkou K, Vougioula O, Tsolia M, Spyridis N

Clin Infect Dis. 2015 Nov 15;61(10):1624-5

26. Interferon gamma inducible protein-10 in the diagnosis of paediatric tuberculosis infection in a low TB incidence country

Amanatidou V, Critselis E, Trochoutsou A, Soldatou A, Bebetatou K, Spyridis N, Papadopoulos NG, Tsolia MN

Int J Tuberc Lung Dis. 2015 Dec;19(12):1463-9

27. Short course regimens of Liposomal amphotericin B for the treatment of Mediterranean visceral Leshmaniasis in children: an 11 year retrospective study at a tertiary care center

            Krepis P, Argyri I, Krepi A, Syrmou A, Spyridis N, Tsolia M

            Pediatr Infect Dis J. 2017 Sep;36(9):849-854

28. Immunogenicity and safety of the inactivated Hepatitis A vaccine in children with Juvenile Arthritis on methotrexate treatment; A matched case cohort study

Maritsi D, Coffin S, Argyri I, Vartzelis G, Spyridis N, Tsolia M

Clinical and Experimental Rheumatology. Jul-Aug;35(4):711-715

29. Emergence of a Staphylococcus aureus Clone Resistant to Mupirocin and Fusidic Acid Carrying Exotoxin Genes and Causing Mainly Skin Infections.

Doudoulakakis A, Spiliopoulou I, Spyridis N, Giormezis N, Kopsidas J, Militsopoulou M, Lebessi E, Tsolia M.

J Clin Microbiol. 2017 Aug;55(8):2529-2537.

30. An 11-Year-Old Male With Vertebral Osteomyelitis and a Paraspinal Abscess.

Kopsidas I, Margariti R, Gavra M, Syngelou A, Zambakidis C, Tsolia M, Nikolaidis N, Spyridis N.

Pediatr Infect Dis J. 2018 Dec;37(12):e341-e343

31. Decreased antibodies against rubella in previously vaccinated treatment-naïve childhood systemic lupus erythematous patients: a prospective case-control study.

Maritsi DN, Coffin S, Onoufriou M, Spyridis N, Tsolia MN.

Scand J Rheumatol. 2019 Jan;48(1):74-76.

32. Antibody status against measles in previously vaccinated childhood systemic  lupus erythematosus patients: a prospective case-control study.

Maritsi DN, Vartzelis G, Kopsidas J, Spyridis N, Tsolia MN.

Rheumatology (Oxford). 2018 Aug 1;57(8):1491-1493

33. Epidemiology of infections and antimicrobial use in Greek Neonatal Units.

Gkentzi D, Kortsalioudaki C, Cailes BC, Zaoutis T, Kopsidas J, Tsolia M, Spyridis N, Siahanidou S, Sarafidis K, Heath PT, Dimitriou G; Neonatal Infection Surveillance Network in Greece.

Arch Dis Child Fetal Neonatal Ed. 2019 May;104(3):F293-F297

34. Establishing nationally representative central line-associated bloodstream infection surveillance data for paediatric patients in Greece.

Kouni S, Tsolia M, Roilides E, Dimitriou G, Tsiodras S, Skoutelis A, Kourkouni E, Gkentzi D, Iosifidis E, Spyridis N, Kopsidas I, Karakosta P, Tsopela GC, Spyridaki I, Kourlaba G, Coffin S, Zaoutis ET; PHIG Investigators.

J Hosp Infect. 2019 Jan;101(1):53-59

35. Risk Factors Associated With Accelerated Rubella IgG Antibody Loss in Previously Vaccinated, Treatment-Naive Patients With Juvenile Systemic Lupus Erythematosus: A Prospective Study.

Maritsi DN, Eleftheriou I, Vartzelis G, Spyridis N, Tsolia MN.

Arthritis Rheumatol. 2019 Jun;71(6):1022-1023

36. Long-term preservation of measles and rubella specific-IgG antibodies in children with enthesitis related arthritis on anti-TNFα treatment: a prospective controlled study.

Maritsi DN, Kopsidas I, Vartzelis G, Spyridis N, Tsolia MN.

Rheumatology (Oxford). 2019 Sep 1;58(9):1686-1688

37. Etiology and Outcome of Candidemia in Neonates and Children in Europe: An 11-year Multinational Retrospective Study.

Warris A, Pana ZD, Oletto A, Lundin R, Castagnola E, Lehrnbecher T, Groll AH, Roilides E, Andersen CT, Arendrup MC, Arsenijevic VA, Bianchini S, von Both U, Chmelnik M, Controzzi T, Emonts M, Esposito S, Ferreras-Antolin L, Henriet S, Iosifidis E, Irwin A, Kopsidas J, Lagrou K, Lyall H, Casteleiro AM, Mesini A, Olbrich P, Paulus S, Lausch KR, Soler-Palacin P, Spyridis N, Strenger V, Theodoraki M, Wolfs T; EUROCANDY Study Group**; **EUROCANDY study group:.

Pediatr Infect Dis J. 2020 Feb;39(2):114-120

38. The Jumping Up (J-Up) Test: Making the Diagnosis of Acute Appendicitis Easier in Children.

Tzortzopoulou AK, Giamarelou P, Tsolia M, Spyridis N, Vakaki M, Passalides A, Zavras N.

Glob Pediatr Health. 2019 Nov 11;6:2333794X19884824

39. A Survey on National Pediatric Antibiotic Stewardship Programs, Networks and Guidelines in 23 European Countries.

Kopsidas I, Vergnano S, Spyridis N, Zaoutis T, Patel S.

Pediatr Infect Dis J. 2020 Nov;39(11):e359-e362

40. Eosinophilic leukaemoid reaction and myocardial involvement in a male adolescent with Toxocara canis infection.

Krepis P, Spyridis N, Maritsi DN, Tsekoura V, Kossiva L.

J Paediatr Child Health. 2020 Sep 17

41. BCG Vaccine Protection against TB Infection among Children Older than 5 Years in Close Contact with an Infectious Adult TB Case.

Syggelou A, Spyridis N, Benetatou K, Kourkouni E, Kourlaba G, Tsagaraki M, Maritsi D, Eleftheriou I, Tsolia M.

J Clin Med. 2020 Oct 8;9(10):3224

42. Pericarditis as the main clinical manifestation of COVID-19 in adolescents

          Dimopoulou D, Spyridis N, Dasoula F, Krepis P, Eleftheriou E, Liaska M, Servos G,      Maritsi D, Tsolia M

            Pediatr Infect Dis J 2021 May 1;40(5):e197-e199

43. 43. Reducing duration of antibiotic use for presumed neonatal early onset sepsis in Greek NICUs. A “low hanging fruit approach

Kopsidas I, Tsopela GC, Molocha NM, Bouza E, Chorafa E, Chorianopoulou E,       Giapros V, Gkentzi D, Gkouvas T, Kapetanaki A, Karachristou K, Karavana G, Kourkouni E, Kourlaba G, Lithoxopoulou M, Papaevangelou V, Polychronaki M,          Roilides E, Siahanidou T, Stratiki E, Syrogiannopoulos GA, Triantafyllou C, Tsolia MN, Tsouvala E, Zaoutis T, Spyridis N, Preventing Hospital-Acquired Infections        In Greece PHiG Investigators.

            Antibiotics (Basel). 2021 Mar 9:10(3):275

44. 44. Pericarditis as the main clinical manifestation of COVD-19 in adolescents

Dimopoulou D, Spyridis N, Dasoula F, Krepis P, Eleftheriou E, Liaska M, Servos G, Maritsi D, Tsolia M

Pediatr Infect Dis J. 2021 May 1;40(5):e197-e199

45. Real life evaluation of a COVID-19 rapid antigen detection test in hospitalized children.

 Eleftheriou I, Dasoula F, Dimopoulou D, Lebessi E, Serafi E, Spyridis N, Tsolia M.

 J Med Virol. 2021 Oct:93(10): 6040-6044                   

46. Sinus Bradycardia in children treated with Remdesivir for COVID-19

Eleftheriou I, Liaska M, Krepis P, Dasoula F, Dimopoulou D, Spyridis N, Tsolia M

Pediatr Infect Dis J. 2021 Sep 1;40(9):e356

47. Predictive factors for gram negative Versus gram positive bloodstream infections in children with cancer

Sfetsiori AE, Doganis D, Doudoulakakis A, Spyridis N, Pourtsidis A, Servitzoglou M, Nikita M, Papachristidou S, Magkou E, Dana H, Lebessi E, Kosmidis H, Baka M, Tsolia M.

J Pediatr Hematol Oncol. 2022 Mar 1;44(2):e368-e37

48. Safety and tolerability of the COVID-19 messenger RNA vaccine in adolescents with JIA treated with TNF inhibitors

Dimopoulou D, Spyridis N, Vartzelis G, Tsolia MN, Maritsi DN.

Arthritis Rheumatol. 2022 Feb;74(2):365-366

49. Potential benefit from the implementation of the Kaiser Permanente neonatal early onset sepsis calculator on clinical management of neonates with presumed sepsis

Kopsidas I, Molocha NM, Kourkouni E, Coffin S, Gkentzi D, Chorianopoulou E, Dimitriou G, Kapetanaki A, Karavana G, Lithoxopoulou M, Polychronaki M, Roilides E, Triantafyllidou P, Triantafyllou C, Tsopela GC, Tsouvala E, Tsolia MN, Zaoutis T, Spyridis N

Eur J Pediatr. 2022 Mar;181(3):1001-1008. 

50. Favorable outcome in infants hospitalized with COVID-19: Single Center Experience form Athens, Greece

Dimopoulou D, Liaska MV, Eleftheriou I, Kourkouni E, Tsolia M, Spyridis N.

Indian Pediatr. 2022 Jun 11:S097475591600434. Online ahead of print.

51. 51. Immunogenicity 6 months post COVID-19 m RNA-vaccination among adolescents with JIA on treatment with TNF-inhibitors

Dimopoulou D, Tsolia MN, Spyridis N, Maritsi DN.

Rheumatology (Oxford). 2022 Jul 5:keac352. doi: 10.1093/rheumatology/keac352. Online ahead of print.

52. 52. Safety and tolerability of the COVID-19 mRNA vaccine in adolescents with JIA treated with TNF inhibitors

Dimopoulou D, Spyridis N, Vartzelis G, Tsolia MN, Maritsi DN.

Arthritis Rheumatol 2022 Feb;74(2):365-366

53. 53. Hand Hygiene compliance rates in 9 Pediatric Intensive Care Units across Europe: reslts fro the RANIN in KIDS network

Kopsidas I, De Luca M, Bielicki J, Blázquez-Gamero D, von Both U, Ciliento G, Epalza C, Goycochea Validivia WA, Kolberg L, Lutsar I, Machaira M, Neth O, Oletto A, Tsolia MN, Viltrop AL, Zaoutis T, Spyridis N.

Pediatr Infect Dis J. 2022 Jul 29. doi: 10.1097/INF.0000000000003658. Online ahead of print.

54. 54. A new score for the diagnosis of complicated appendicitis on children-Complicate appendicitis Pediatric Score.

Tzortzopoulou AK, Tsolia M, Spyridis N, Giamarelou P, Sfakiotaki R, Passalides A, Zavras N.

1. Indian Assoc. Pediatr Surg. 2022;27(4):410-418
2. 55. Decreasing incidence of the MIS-C over 3 pandemic waves

Eleftheriou I, Maritsi D, Lampidi S, Charisi K, Vantsi P, Skourti K, Filippatos F, Amplianitis I, Dimou D, Papadopoulou-Legbelou K, Papadopoulou-Alataki E, Kampouridou P, Koletsi P, Fotis L, Vergadi E, Gkentzi D, Farmaki E, Papaevangelou V, Galanakis E, Grivea IN, Syrogiannopoulos GA, Spoulou V, Spyridis N, Michos A, Roilides E, Tsolia MN.

Pediatr Infect Dis J. 2023 Feb 1;42(2):122-124

56. A national study of antibiotic use in Greek pediatric hematology oncology and bone marrow transplant units

Mantadakis E, Kopsidas I, Coffin S, Dimitriou G, Gkentzi D, Hatzipantelis E, Kaisari A, Kattamis A, Kourkouni E, Papachristidou S, Papakonstantinou E, Polychronopoulou S, Roilides E, Spyridis N, Tsiodras S, Tsolia MN, Tsopela GC, Zaoutis T, Tragiannidis A.

Antimicrob Steward Health Epidemiol. 2022Apr 26;2(1):e71

57. Management of children with febrile seizures: a Greek national survey

Kopsidas I, Dasoula FE, Kourkouni E, Krepi A, Mystakelis HA, Spyridis N,   Vartzelis G.

Eur J Pediatr.2023 Jul;182(7):3293-3300

58. 58. Multisystem inflammatory syndrome in children (MIS-C): A nationwide collaborative study in the Greek population

Lampidi S, Maritsi D, Charakida M, Eleftheriou I, Farmaki E, Spyridis N, Charisi K, Vantsi P, Filippatos F, Skourti K, Papadopoulou-Alataki E, Papadopoulou-Legbelou K, Kampouridou P, Grivea IN, Vergadi E, Gkentzi D, Dimou D, Koletsi P, Fotis L, Liakopoulou T, Agrafiotou A, Kourtesi K, Tsolas G, Kafetzis D, Papaevangelou V, Dimitriou G, Galanakis E, Syrogiannopoulos GA, Spoulou V, Michos A, Roilides E, Tsolia MN.

Eur J Pediatr. 2024 Apr;183(4):1693-1702

Δημοσιεύσεις ως συνεργαζόμενος ερευνητής

59. The antibiotic resistance and prescribing in European Children project: a neonatal and pediatric antimicrobial web-based point prevalence survey in 73 hospitals worldwide.

Versporten A, Sharland M, Bielicki J, Drapier N, Vankerckhoven V, Goossens H; ARPEC Project Group Members.

Pediatr. Infect. Dis J. 2013 Jun;32(6)

60. Antibiotic Resistance Prevalence in Routine Bloodstream Isolates from Children’s Hospitals Varies Substantially from Adult Surveillance Data in Europe.

Bielicki JA, Lundin R, Sharland M; ARPEC Project.

Pediatr Infect Dis J. 2015 Aug;70(8):2405-8

61. Selecting appropriate empirical antibiotic regimens for paediatric bloodstream infections: application of a Bayesian decision model to local and pooled antimicrobial resistance surveillance data.

Bielicki JA, Sharland M, Johnson AP, Henderson KL, Cromwell DA; Antibiotic Resistance and Prescribing in European Children project.

J Antimicrob Chemother. 2016 Mar;71 (13):794-802

62. The Worldwide Antibiotic Resistance and Prescribing in European Children (ARPEC) point prevalence survey: developing hospital-quality indicators of antibiotic prescribing for children.

Versporten A, Bielicki J, Drapier N, Sharland M, Goossens H; ARPEC project group.

J Antimicrob Chemother. 2016 Apr;71(14):1106-17

63. Children and adolescents with SARS-CoV-2 Infection. Epidemiology, Clinical Course and Viral Loads

            Maltezou HC, Magaziotou I, Dedoukou X, Eleftheriou E, Raftopoulos V, Michos A, Lourida A, Panopoulou M, Stamoulis K, Papaevangelou V, Petinaki E, Mentis A, Papa A, Tsakris A, Roilides E, Syrogiannopoulos GA, Tsolia M; for Greek Study Group on SARS-CoV-2 Infections in Children.

                        Pediatr Infect Dis J. 2020 Dec;39(12):e388-e392

64. Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control-control study (EURECA)

Salvador Pérez-Galera ^1 2, Jose M Bravo-Ferrer ¹, María Paniagua ¹, Tomislav Kostyanev ^3 4, Marlieke E A de Kraker ⁵, Jan Feifel ⁶, Jesús Sojo-Dorado ¹, Joost Schotsman ⁷, Rafael Cantón ^8 9, George L Daikos ¹⁰, Biljana Carevic ¹¹, Gorana Dragovac ¹², Lionel K Tan ¹³, Lul Raka ¹⁴, Adriana Hristea ¹⁵, Pierluigi Viale ¹⁶, Murat Akova ¹⁷, Jose María Reguera ¹⁸, Lucía Valiente de Santis ¹⁸, Julián Torre-Cisneros ^9 19, Ángela Cano ¹⁹, Emmanuel Roilides ²⁰, Lili Radulovic ²¹, Cenk Kirakli ²², Evelyn Shaw ^9 23, Matthew E Falagas ^24 25, Vicente Pintado ^8 9, Herman Goossens ³, Marc J Bonten ⁶, Belén Gutiérrez-Gutiérrez ^1 9, Jesús Rodriguez-Baño ^1 9; COMBACTE-CARE-EURECA Team

EClinical Medicine 2023 Feb 27;57:101871

65. Genomic investigations of unexplained acute hepatitis in children

Morfopoulou S, Buddle S, Torres Montaguth OE, Atkinson L, Guerra-Assunção JA, Moradi Marjaneh M, Zennezini Chiozzi R, Storey N, Campos L, Hutchinson JC, Counsell JR, Pollara G, Roy S, Venturini C, Antinao Diaz JF, Siam A, Tappouni LJ, Asgarian Z, Ng J, Hanlon KS, Lennon A, McArdle A, Czap A, Rosenheim J, Andrade C, Anderson G, Lee JCD, Williams R, Williams CA, Tutill H, Bayzid N, Martin Bernal LM, Macpherson H, Montgomery KA, Moore C, Templeton K, Neill C, Holden M, Gunson R, Shepherd SJ, Shah P, Cooray S, Voice M, Steele M, Fink C, Whittaker TE, Santilli G, Gissen P, Kaufer BB, Reich J, Andreani J, Simmonds P, Alrabiah DK, Castellano S, Chikowore P, Odam M, Rampling T, Houlihan C, Hoschler K, Talts T, Celma C, Gonzalez S, Gallagher E, Simmons R, Watson C, Mandal S, Zambon M, Chand M, Hatcher J, De S, Baillie K, Semple MG; DIAMONDS Consortium; PERFORM Consortium; ISARIC 4C Investigators; Martin J, Ushiro-Lumb I, Noursadeghi M, Deheragoda M, Hadzic N, Grammatikopoulos T, Brown R, Kelgeri C, Thalassinos K, Waddington SN, Jacques TS, Thomson E, Levin M, Brown JR, Breuer J.

Nature. 2023 May;617(7961):564-573

66. 66. Adeno-associated virus 2 infection in children with non-A-E hepatitis.

Ho A, Orton R, Tayler R, Asamaphan P, Herder V, Davis C, Tong L, Smollett K, Manali M, Allan J, Rawlik K, McDonald SE, Vink E, Pollock L, Gannon L, Evans C, McMenamin J, Roy K, Marsh K, Divala T, Holden MTG, Lockhart M, Yirrell D, Currie S, O’Leary M, Henderson D, Shepherd SJ, Jackson C, Gunson R, MacLean A, McInnes N, Bradley-Stewart A, Battle R, Hollenbach JA, Henderson P, Odam M, Chikowore P, Oosthuyzen W, Chand M, Hamilton MS, Estrada-Rivadeneyra D, Levin M, Avramidis N, Pairo-Castineira E, Vitart V, Wilkie C; DIAMONDS Consortium; ISARIC4C Investigators; Palmarini M, Ray S, Robertson DL, da Silva Filipe A, Willett BJ, Breuer J, Semple MG, Turner D, Baillie JK, Thomson EC.

Nature 2023 May;617(7961):555-563

67. 67. Evaluation of Autoantibody Binding to Cardiac Tissue in Multisystem Inflammatory Syndrome in Children and COVID-19 Vaccination-Induced Myocarditis

Harsita Patel ¹, Amalia Sintou ², Rasheda A Chowdhury ², Stephen Rothery ², Alma Octavia Iacob ^2 3, Sanjay Prasad ³, Peter P Rainer ^4 5, Federico Martinón-Torres ^6 7 8, Vanessa Sancho-Shimizu ^1 9 10, Chisato Shimizu ^11 12, Kirsten Dummer ^11 12, Adriana H Tremoulet ^11 12, Jane C Burns ^11 12, Susanne Sattler ^2 4, Michael Levin ¹; DIAMONDS consortium

JAMA Netw Open. 2023 May 1;6(5):

68. 68. Relationship between molecular pathogen detection and clinical disease in febrile children across Europe: a multicentre, prospective observational study

Priyen Shah ¹, Marie Voice ², Leonides Calvo-Bado ², Irene Rivero-Calle ^3 4, Sophie Morris ², Ruud Nijman ¹, Claire Broderick ¹, Tisham De ¹, Irini Eleftheriou ⁵, Rachel Galassini ¹, Aakash Khanijau ⁶, Laura Kolberg ⁷, Mojca Kolnik ⁸, Aleksandra Rudzate ⁹, Manfred G Sagmeister ¹⁰, Nina A Schweintzger ¹⁰, Fatou Secka ¹¹, Clare Thakker ¹, Fabian van der Velden ¹², Clementien Vermont ¹³, Katarina Vincek ⁸, Philipp K A Agyeman ¹⁴, Aubrey J Cunnington ¹, Ronald De Groot ¹⁵, Marieke Emonts ^12 16, Katy Fidler ¹⁷, Taco W Kuijpers ^18 19, Marine Mommert-Tripon ²⁰, Karen Brengel-Pesce ²⁰, Francois Mallet ²⁰, Henriette Moll ²¹, Stéphane Paulus ²², Marko Pokorn ^8 23, Andrew Pollard ²², Luregn J Schlapbach ²⁴, Ching-Fen Shen ^25 26, Maria Tsolia ⁵, Effua Usuf ¹¹, Michiel van der Flier ^15 27, Ulrich von Both ^7 28, Shunmay Yeung ²⁹, Dace Zavadska ^9 30, Werner Zenz ¹⁰, Victoria Wright ¹, Enitan D Carrol ^6 31, Myrsini Kaforou ¹, Federico Martinon-Torres ^3 4 32, Colin Fink ², Michael Levin ¹, Jethro Herberg ¹; PERFORM consortium

Lancet reg Health Eur. 2023 Jul 26;32:100682

69. 69. A multi-platform approach to identify a blood-based host protein signature for distinguishing between bacterial and viral infections in febrile children (PERFORM): a multi-cohort machine learning study

Heather R Jackson ¹, Judith Zandstra ², Stephanie Menikou ¹, Melissa Shea Hamilton ¹, Andrew J McArdle ¹, Roman Fischer ³, Adam M Thorne ⁴, Honglei Huang ⁵, Michael W Tanck ⁶, Machiel H Jansen ⁷, Tisham De ¹, Philipp K A Agyeman ⁸, Ulrich Von Both ⁹, Enitan D Carrol ¹⁰, Marieke Emonts ¹¹, Irini Eleftheriou ¹², Michiel Van der Flier ¹³, Colin Fink ¹⁴, Jolein Gloerich ¹⁵, Ronald De Groot ¹⁵, Henriette A Moll ¹⁶, Marko Pokorn ¹⁷, Andrew J Pollard ¹⁸, Luregn J Schlapbach ¹⁹, Maria N Tsolia ¹², Effua Usuf ²⁰, Victoria J Wright ¹, Shunmay Yeung ²¹, Dace Zavadska ²², Werner Zenz ²³, Lachlan J M Coin ²⁴, Climent Casals-Pascual ²⁵, Aubrey J Cunnington ¹, Federico Martinon-Torres ²⁶, Jethro A Herberg ¹, Marien I de Jonge ²⁷, Michael Levin ¹, Taco W Kuijpers ², Myrsini Kaforou ²⁸; PERFORM consortium

Lancet Digit Health. 2023 Nov;5(11):e774-e785

70. 70. Attributable mortality of infections caused by carbapenem-resistant Enterobacterales: results from a prospective, multinational case-control-control matched cohorts study (EURECA)

María Paniagua-García ¹, Jose M Bravo-Ferrer ², Salvador Pérez-Galera ³, Tomislav Kostyanev ⁴, Marlieke E A de Kraker ⁵, Jan Feifel ⁶, Zaira R Palacios-Baena ⁷, Joost Schotsman ⁸, Rafael Cantón ⁹, George L Daikos ¹⁰, Biljana Carevic ¹¹, Gorana Dragovac ¹², Lionel K Tan ¹³, Lul Raka ¹⁴, Adriana Hristea ¹⁵, Pierluigi Viale ¹⁶, Murat Akova ¹⁷, Ángela Cano ¹⁸, Jose María Reguera ¹⁹, Alessandro Bartoloni ²⁰, Simin-Aysel Florescu ²¹, Serban Benea ¹⁵, Ljiljana Bukarica ²², Ángel Asensio ²³, Volkan Korten ²⁴, Hajo Grundmann ²⁵, Herman Goossens ²⁶, Marc J Bonten ⁶, Belén Gutiérrez-Gutiérrez ²⁷, Jesús Rodríguez-Baño ⁷; COMBACTE-CARE-EURECA team

Clin Microbiol Inect. 2024 Feb;30(2):223-230

71. 71. Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales: a nested case-control-control study

Hongyu Zhou ^1 2, Niccolò Buetti ^1 3, Salvador Pérez-Galera ^4 5, Jose Bravo-Ferrer ^5 6, Belén Gutiérrez-Gutiérrez ^5 6 7, María Paniagua-García ^5 7 8, Jan Feifel ⁹, Julien Sauser ¹, Tomi Kostyanev ^10 11, Rafael Canton ^7 12, Lionel K Tan ¹³, Dimitris Basoulis ¹⁴, Vicente Pintado ^7 15, Emmanuel Roilides ¹⁶, Gorana Dragovac ¹⁷, Julian Torre-Cisneros ^7 18, Deana Mediç ¹⁷, Murat Akova ¹⁹, Herman Goossens ¹⁰, Marc Bonten ²⁰, Stephan Harbarth ¹, Jesus Rodriguez-Baño ^5 6 7, Marlieke E A De Kraker ¹; COMBACTE- EURECA project team

J Antimicrob Chemother. 2024 Sep 3;79(9):2132-2141